Updates on our COVID-19 Vaccines
Sanofi and GSK announced on May 27 the start of a phase 3 clinical trial for their COVID-19 recombinant vaccine candidate
Where the Light Meets the Dark
To celebrate our LGBTQIA+ community during Pride Month 2021, Paulo Pires from Brazil shares the challenges of moving to a new country as a black, gay man
2020 Integrated Report
An immersive journey to discover Sanofi’s breakthrough science, people, strategy and contribution to society
Our New Ambitions for Diversity and Inclusion
We are doing more to make an impact in the world through who we are, what we do, and the way we do it, with everyone being truly represented and included
-
Press releases2021-08-05MMMM DD YYYYPhase 3 trial of Libtayo® (cemiplimab) combined with chemotherapy stopped early due to significant improvement in overall survival in patients with first-line advanced non-small cell lung cancer